Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G M Oremek

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Anticancer Research|June 25, 2003
Pro-gastrin-releasing peptide (Pro-GRP), a tumor marker for small cell lung cancerG M Oremek, N Sapoutzis
Pathology Research International|December 3, 2011
Value of Procollagen Type I Aminoterminal Propeptide in Women with Breast Cancer with regard to MetastasesA Clouth, G M Oremek
European Journal of Gynaecological Oncology|February 17, 2012
Value of TRAcP 5b as a diagnostic marker for detection of bone metastases in patients with breast cancerM J Hung, G M Oremek
Clinical Chemistry|May 1, 1996
Physical activity releases prostate-specific antigen (PSA) from the prostate gland into blood and increases serum PSA concentrationsG M Oremek, U B Seiffert
Anticancer Research|June 25, 2003
Phospholipids, tumour marker and beta-CrossLaps in diagnosis of gastric carcinomaG M Oremek, N Sapoutzis, M Lorenz
Anticancer Research|April 1, 2009
Procollagen type 1 amino-terminal propeptide: a marker for bone metastases in prostate carcinomaM Klepzig, D Jonas, G M Oremek
Klinicheskaia Laboratornaia Diagnostika|May 3, 2008
[Comparison of two methods for rapid determination of C-reactive protein with the Tina-quant]G M Oremek, R Luksaite, I Bretschneider
Clinica Chimica Acta; International Journal of Clinical Chemistry|July 30, 1996
Kinetic differences between creatine kinase-isoenzyme MB (CK-MB) and c-troponin-T in patients with myocardial damageG M Oremek, U B Seiffert, F Beyersdorf
Anticancer Research|June 25, 2003
Complexed PSA in routine diagnosisG M Oremek, N Sapoutzis, F Eden, et al.
Anticancer Research|June 25, 2003
Pyruvate kinase type tumor M2 plasma levels in patients afflicted with rheumatic diseasesG M Oremek, R Müller, N Sapoutzis, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Anticancer Research|June 25, 2003
Pro-gastrin-releasing peptide (Pro-GRP), a tumor marker for small cell lung cancerG M Oremek, N Sapoutzis
Pathology Research International|December 3, 2011
Value of Procollagen Type I Aminoterminal Propeptide in Women with Breast Cancer with regard to MetastasesA Clouth, G M Oremek
European Journal of Gynaecological Oncology|February 17, 2012
Value of TRAcP 5b as a diagnostic marker for detection of bone metastases in patients with breast cancerM J Hung, G M Oremek
Clinical Chemistry|May 1, 1996
Physical activity releases prostate-specific antigen (PSA) from the prostate gland into blood and increases serum PSA concentrationsG M Oremek, U B Seiffert
Anticancer Research|June 25, 2003
Phospholipids, tumour marker and beta-CrossLaps in diagnosis of gastric carcinomaG M Oremek, N Sapoutzis, M Lorenz
Anticancer Research|April 1, 2009
Procollagen type 1 amino-terminal propeptide: a marker for bone metastases in prostate carcinomaM Klepzig, D Jonas, G M Oremek
Klinicheskaia Laboratornaia Diagnostika|May 3, 2008
[Comparison of two methods for rapid determination of C-reactive protein with the Tina-quant]G M Oremek, R Luksaite, I Bretschneider
Clinica Chimica Acta; International Journal of Clinical Chemistry|July 30, 1996
Kinetic differences between creatine kinase-isoenzyme MB (CK-MB) and c-troponin-T in patients with myocardial damageG M Oremek, U B Seiffert, F Beyersdorf
Anticancer Research|June 25, 2003
Complexed PSA in routine diagnosisG M Oremek, N Sapoutzis, F Eden, et al.
Anticancer Research|June 25, 2003
Pyruvate kinase type tumor M2 plasma levels in patients afflicted with rheumatic diseasesG M Oremek, R Müller, N Sapoutzis, et al.
Pageof 3